Address
300 Connell Drive
Berkeley Heights, NJ 07922
United States of America (the)
Phone
908 517 9500
Website
Sector
Healthcare
Industry
Biotechnology
Employees
64
First IPO Date
May 13, 2010
| Name | Title | Pay | Year Born |
| Joseph Todisco | CEO & Chairman of the Board of Directors | 1.61M | 1976 |
| Michael Seckler | Executive Vice President & Chief Commercial Officer | 561,571 | 1966 |
| Matthew T. David | EVP & Chief Business Officer | 634,855 | 1978 |
| Susan Blum | Executive Vice President & Chief Financial Officer | 634,855 | 1973 |
| Elizabeth Hurlburt | Executive Vice President, Chief Operating Officer & Chief Integration Officer | 959,370 | 1979 |
| Kaufman Beth Zelnick | EVP, Chief Legal and Compliance Officer & Corporate Secretary | 981,592 | 1961 |
| Jared L. Crandon | Executive Director of Clinical Portfolio Management | 0 | N/A |
| Donna Ucci | Senior Vice President & Head of Global Quality | 0 | N/A |
| Peter Sullivan BCOP | Senior Vice President of Market Access | 0 | N/A |
| Tushar Mukherjee | Senior Vice President & Head of Technical Operations | 0 | N/A |
| Beth Steinbrenner | SVP & Chief Human Resource Officer | 0 | N/A |
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of medical treatments for the prevention and care of infectious and inflammatory conditions, serving markets both in the United States and internationally. Its leading product candidate, DefenCath/Neutrolin, represents a novel anti-infective solution. This treatment aims to diminish and avert catheter-related infections and blood clots in patients who utilize central venous catheters for medical procedures such as hemodialysis, total parenteral nutrition, and oncology care. Incorporated in 2006, the company initially operated as Picton Holding Company, Inc. until officially adopting the name CorMedix Inc. in January 2007. Its corporate headquarters are located in Berkeley Heights, New Jersey.